ArticleFrontiers in surgery2026
Comprehensive perioperative management of a giant neurofibroma complicated by hemorrhagic shock: a case report.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant neurofibromas are rare benign peripheral nerve sheath tumors, most often occurring in association with neurofibromatosis type I. Tumor rupture may be followed by massive bleeding and hemorrhagic shock, posing life-threatening challenges during perioperative management. This report describes the multidisciplinary perioperative care of a patient with a ruptured giant neurofibroma complicated by hemorrhagic shock. A 39-year-old man with a history of congenital neurofibromatosis presented with acute swelling and pain in the right lumbar region and abdomen following trauma. Computed tomography revealed a massive retroperitoneal hematoma secondary to tumor rupture. The patient underwent emergency debridement and hemostasis under general anesthesia. Intraoperatively, approximately 3,000 mL of clotted blood was evacuated, and diffuse bleeding from the tumor cavity was controlled by suture ligation, electrocautery, and compression packing. Due to severe hemorrhagic shock, the patient required transfusion support, vasoactive drugs, mechanical ventilation, and intensive care. The surgical team focused on precise intraoperative positioning, thermal management, hemodynamic monitoring, transfusion coordination, aseptic technique, and postoperative wound compression and infection prevention. The patient's bleeding was temporarily controlled by compression and intensive supportive therapy. Subsequent multidisciplinary consultation guided further management. The patient achieved hemodynamic stabilization but required prolonged critical care due to the large wound area and ongoing risk of infection. This case highlights the pivotal role of perioperative in managing catastrophic bleeding in giant neurofibroma surgery. Individualized assessment, close coordination with surgical and anesthesia teams, and evidence-based interventions were crucial for maintaining stability and optimizing patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.